Navigation Links
Novartis Phase II LBH589 data show substantial disease control and tumor reduction in extensively pretreated Hodgkin lymphoma patients
Date:12/6/2010

ll transplant. 52nd ASH Annual Meeting and Exposition. 2010. Abstract #169. Available at http://ash.confex.com/ash/2010/webprogram/Paper34050.html. Accessed November 2010.
  • McBride NC, Cavenagh JD, Ward MC, et al. Liposomal daunorubicin (DaunoXome) in combination with cyclophosphamide, vincristine and prednisolone (COP-X) as salvage therapy in poor-prognosis non-Hodgkins lymphoma. Leuk Lymphoma. 2001Jun;42(1-2):89-98.
  • NCCN Clinical Practice Guidelines in Oncology™ Hodgkin Lymphoma. V.2.2010. Available at http://www.nccn.org/professionals/physician_gls/PDF/hodgkins.pdf. Accessed November 2010.
  • Engert A, Eichenauer DA, Dreyling M; on behalf of the ESMO Guidelines Working Group. Hodgkin's lymphoma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up. Ann Oncol. 2009;20 suppl 4: iv108-iv109.
  • Younes A, Ong, T-C, Ribrag V, et al. Efficacy of panobinostat in Phase II study in patients with relapsed/refractory Hodgkin lymphoma (HL) after high-dose chemotherapy with autologous stem cell transplant.  Blood (ASH Annual Meeting Abstracts), 2009;114:923.
  • A Phase III randomized, double blind, placebo controlled multi-center study of panobinostat for maintenance of response in patients with Hodgkin's lymphoma. Available at http://www.clinicaltrials.gov/ct2/show/NCT01034163. Accessed November 2010.
  • Straus D. Relapsed and refractory Hodgkin lymphoma. Lymphoma Research Foundation. Available at http://www.lymphoma.org/atf/cf/%7B0363cdd6-51b5-427b-be48-e6af871acec9%7D/HL09RELREF.PDF. Accessed November 2010.
  • The Leukemia & Lymphoma Society. Hodgkin lymphoma facts & statistics. Availa
    '/>"/>

  • SOURCE Novartis
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7

    Related medicine technology :

    1. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
    2. Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting
    3. Emisphere Announces Recruitment of Novartis Phase III Study for Oral Osteoporosis Treatment
    4. Video: Novartis Vaccines and PTA Battle Flu: Public Health Vaccination Initiative Urges Families Lets Fight Flu Together!
    5. More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies
    6. Video: Data on More Than 15 Novartis Oncology Compounds at ASCO Highlight Progress Toward Targeted Therapies for Diverse Tumor Types
    7. Juvenile Diabetes Research Foundation, The Genomics Institute of the Novartis Research Foundation Announce Innovative Diabetes Drug Discovery and Development Partnership
    8. US FDA Approves Extavia(R) - the First in a New Portfolio of Planned MS Therapies from Novartis to Help Patients with this Devastating Disease
    9. Results In The New England Journal Of Medicine Confirm Novartis Drug Femara(R) Is Superior To Tamoxifen After Breast Cancer Surgery
    10. Novartis Enters Into Agreement for Exclusive US and Canadian Rights to Fanapt(TM), an FDA-Approved Oral Therapy for Schizophrenia
    11. Novartis Pharmaceuticals Corporation Prevails in Medicaid Pricing Case Before Alabama Supreme Court
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/6/2015)... Inc. (Nasdaq: NXTM ), a leading manufacturer of ... that exceed the top end of its guidance range. ... 2015 increased 10 percent to $79.5 million, compared with ... 2014. The Company,s revenue guidance range for the first ... was driven by outperformance in the System One segment ...
    (Date:5/6/2015)... Eli Lilly and Company (NYSE: LLY ... delivery and device innovation center in Cambridge, ... help attract top scientists and bioengineers, as well as ... The Lilly Cambridge Innovation Center, a makerspace located in ... organizations to explore how emerging technologies and connectivity can ...
    (Date:5/6/2015)... 2015 According to a ... Market by Technology (Precipitation, Dialysis, Electrophoresis, Western Blotting, ... Kits, Reagents, Resins) by Application & End User ...  the global Protein Purification and Isolation Market was ... is expected to reach $ 6,370 Million by ...
    Breaking Medicine Technology:NxStage Reports First Quarter 2015 Financial Results And Exceeds Guidance 2NxStage Reports First Quarter 2015 Financial Results And Exceeds Guidance 3NxStage Reports First Quarter 2015 Financial Results And Exceeds Guidance 4NxStage Reports First Quarter 2015 Financial Results And Exceeds Guidance 5NxStage Reports First Quarter 2015 Financial Results And Exceeds Guidance 6NxStage Reports First Quarter 2015 Financial Results And Exceeds Guidance 7NxStage Reports First Quarter 2015 Financial Results And Exceeds Guidance 8NxStage Reports First Quarter 2015 Financial Results And Exceeds Guidance 9NxStage Reports First Quarter 2015 Financial Results And Exceeds Guidance 10NxStage Reports First Quarter 2015 Financial Results And Exceeds Guidance 11Eli Lilly and Company Reveals Plan for Innovation Center in Cambridge, Massachusetts 2Eli Lilly and Company Reveals Plan for Innovation Center in Cambridge, Massachusetts 3Protein Purification and Isolation Market Worth $6,370 Million by 2020 2Protein Purification and Isolation Market Worth $6,370 Million by 2020 3Protein Purification and Isolation Market Worth $6,370 Million by 2020 4
    ... LAKES, N.J. and MONTREAL, Oct. 13, 2011 A ... gene testing analysis found that 38 percent of patients ... clots, heart attack and stroke—were also using another drug ... http://photos.prnewswire.com/prnh/20100609/MEDCOLOGO ) The analysis also showed that ...
    ... (NYSE AMEX: ULU ), announced today that it has ... company based in Switzerland, to license Altrazeal® for the European Union. ... the European Union rights to a subsidiary of Melmed Holdings AG ... for the license ULURU will receive a licensing payment and a ...
    Cached Medicine Technology:Putting Gene Tests to Use: More Than a Third of Patients Cannot Properly Metabolize Plavix® 2Putting Gene Tests to Use: More Than a Third of Patients Cannot Properly Metabolize Plavix® 3Putting Gene Tests to Use: More Than a Third of Patients Cannot Properly Metabolize Plavix® 4ULURU Inc. Announces Altrazeal® Agreement for the European Market 2ULURU Inc. Announces Altrazeal® Agreement for the European Market 3
    (Date:5/6/2015)... San Mateo, Calif. (PRWEB) May 06, 2015 ... SafeMonk today announced a strategic partnership to ... in the cloud. The two industry-leading companies are teaming ... encryption platform. , “We’re thrilled to welcome ... meaningful to us that the people behind SafeMonk, the ...
    (Date:5/6/2015)... Canadian, OK (PRWEB) May 06, 2015 ... Occupational Health (FOH) agency, operating within the U.S. Department ... of May as National Physical Fitness and Sports Month. ... active living and its importance to health. Throughout ... active, eat well, and get fit. , The HHS ...
    (Date:5/6/2015)... 06, 2015 Most people in the United ... or other care after age 65. But less than half ... it or even talking about it, reports the May 2015 ... risk two problems. One is losing control over the care ... says Dr. David Grabowski, a professor of health care policy ...
    (Date:5/6/2015)... 06, 2015 The Center for Innovative ... has invested in e-Kare, Inc. of Fairfax, VA, a ... monitoring of chronic wounds. , Chronic wounds include pressure, ... wounds that affect over 6.5 million U.S. patients, costing ... spin-off enterprise from the Children’s National Medical Center (CNMC), ...
    (Date:5/6/2015)... May 06, 2015 Spiking drug prices are ... a new survey by The Senior Citizens League ... report higher co-pays and co-insurance costs than expected in 2014 ... for the cost spikes may be tough for many beneficiaries ... high drug prices are commonly associated with brand and newer ...
    Breaking Medicine News(10 mins):Health News:Sookasa Grows Globally With SafeMonk Partnership 2Health News:Sookasa Grows Globally With SafeMonk Partnership 3Health News:Narconon Arrowhead Issues Guide for Physical Fitness and Sports Month 2Health News:Narconon Arrowhead Issues Guide for Physical Fitness and Sports Month 3Health News:Start Planning Now for Long-Term Care, from the May 2015 Harvard Health Letter 2Health News:CIT GAP Funds Invests in e-Kare 2Health News:CIT GAP Funds Invests in e-Kare 3Health News:New Survey By The Senior Citizens League Reveals 61% Had Higher Than Expected Medicare Part D Costs In 2014 2Health News:New Survey By The Senior Citizens League Reveals 61% Had Higher Than Expected Medicare Part D Costs In 2014 3
    ... 2, 2009) New research published in the February issue ... shows a warm-up of 15 to 20 minutes with ... substantial increase in proficiency of surgical skills in surgeons of ... both psychomotor and cognitive skills raises surgeons, alertness to a ...
    ... (NYSE: WTW ) will release its results for ... close on Wednesday, March 4, 2009.The Company has also scheduled ... During the conference call, David Kirchhoff, President and Chief Executive ... quarter and full year results and answer questions from the ...
    ... /PRNewswire/ -- Kirby Lester, LLC, the world,s ... automated technology breakthrough: the KL30 automated dispensing and ... sized and priced for any retail pharmacy or hospital ... per day.Kirby Lester introduced the KL30 today at the ...
    ... CHICAGO, Feb. 2 The American Dietetic Association will pursue ... and recommend to Congress that a primary goal of new ... of our citizens should improve as a result of our ... M. Yadrick. "Nutrition needs to rise as a national priority, ...
    ... Meet in Boise, Idaho, Feb. 7-13 to Promote Acceptance ... World ATLANTA, Feb. 2 Wesley Mosley from ... from around the world to participate in the fifth ... be held in conjunction with the 2009 Special Olympics ...
    ... CarePHOENIX, Feb. 2 In celebration of American ... Annual Public Forum showcasing a live- telecast ... blood vessel disease on Tuesday, February 10, 2009. ... Founder and Medical Director of Arizona Heart Institute ...
    Cached Medicine News:Health News:Journal of American College of Surgeons study finds warm-up helps surgeons improve performance 2Health News:Weight Watchers Announces Fourth Quarter and Full Year 2008 Earnings Conference Call 2Health News:Kirby Lester's New KL30: Fully Automated, Compact System for a Fraction of the Cost of a Robotic Dispenser 2Health News:Kirby Lester's New KL30: Fully Automated, Compact System for a Fraction of the Cost of a Robotic Dispenser 3Health News:American Dietetic Association Announces Agenda for Health Reform 2Health News:Wesley Mosley Selected to Participate in Global Youth Activation Summit During the 2009 Special Olympics World Winter Games 2Health News:Wesley Mosley Selected to Participate in Global Youth Activation Summit During the 2009 Special Olympics World Winter Games 3Health News:Arizona Heart Institute Announces FREE Public Forum Featuring Live Viewing of Surgical Procedures Via High-Definition (HD) Satellite 2
    ... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
    ... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
    ... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
    ... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
    Medicine Products: